Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education, Beijing 100034, China.
Gene. 2013 Dec 1;531(2):363-9. doi: 10.1016/j.gene.2013.08.041. Epub 2013 Aug 27.
Familial juvenile hyperuricemic nephropathy (FJHN) is an autosomal dominant disorder characterized by hyperuricemia and progressive chronic kidney disease. Uromodulin gene (UMOD) mutations, leading to abnormalities of uromodulin intracellular trafficking contribute to the progress of the disease.
We did UMOD screening in three Chinese FJHN families. We thus constructed mutant uromodulin express plasmids by site-mutagenesis from wild type uromodulin vector and transfected them into HEK293 (human embryonic kidney) cells. And then we detected uromodulin expression by western blot and observed intracellular distribution by immunofluorescence.
We found three heterozygous mutations. Mutation Val109Glu (c.326T/A; p.Val109Glu) and mutation Pro236Gln (c.707C/A; p.Pro236Gln) were newly indentified mutations in two distinct families (family F1 and family F3). Another previously reported UMOD mutation Cys248Trp (c.744C/G; p.Cys248Trp) was detected in family F2. Phenotypes varied both within the same family and between different families. Uromodulin expression is abnormal in the patient biopsy. Functional analysis of mutation showed that mutant types of uromodulin were secreted into the supernatant medium much less when compared with wild type. In mutant type uromodulin transfected cells, intracellular uromodulin localized less in the Golgi apparatus and more in endoplasmic reticulum(ER).
Our results suggested that the novel uromodulin mutations found in the Chinese families lead to misfolded protein, which was retained in the endoplasmic reticulum, finally contributed to the phenotype of FJHN.
家族性青少年型高尿酸血症肾病(FJHN)是一种常染色体显性遗传疾病,其特征为高尿酸血症和进行性慢性肾脏病。尿调节素基因(UMOD)突变导致尿调节素细胞内转运异常,从而促进疾病的进展。
我们对三个中国 FJHN 家族进行了 UMOD 筛查。我们通过定点诱变从野生型尿调节素载体构建突变尿调节素表达质粒,并将其转染至 HEK293(人胚肾)细胞中。然后,我们通过 Western blot 检测尿调节素的表达,并通过免疫荧光观察细胞内分布。
我们发现了三个杂合突变。突变 Val109Glu(c.326T/A;p.Val109Glu)和突变 Pro236Gln(c.707C/A;p.Pro236Gln)是在两个不同家族(家族 F1 和家族 F3)中新发现的突变。另一个先前报道的 UMOD 突变 Cys248Trp(c.744C/G;p.Cys248Trp)在家族 F2 中被检测到。同一家庭内和不同家庭之间的表型均存在差异。患者活检中的尿调节素表达异常。突变的功能分析表明,与野生型相比,突变型尿调节素的分泌到上清液中的量明显减少。在突变型尿调节素转染细胞中,细胞内尿调节素在高尔基体中的定位减少,在内质网(ER)中的定位增加。
我们的结果表明,在中国家族中发现的新型尿调节素突变导致错误折叠的蛋白质在内质网中滞留,最终导致 FJHN 的表型。